These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6959522)

  • 1. Heterogeneity and variability in Tourette syndrome.
    Caine ED; Polinsky RJ; Ludlow CL; Ebert MH; Nee LE
    Adv Neurol; 1982; 35():437-42. PubMed ID: 6959522
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic treatment in the Tourette syndrome.
    Barbeau A
    N Engl J Med; 1980 Jun; 302(23):1310-1. PubMed ID: 6929035
    [No Abstract]   [Full Text] [Related]  

  • 3. [Generalized paroxysmal tic (Tourette's syndrome)].
    Badalian LO; Skvortsov IA; Kamennykh LN; Dadali EL; Temin PA
    Klin Med (Mosk); 1979 Sep; 57(9):28-34. PubMed ID: 290841
    [No Abstract]   [Full Text] [Related]  

  • 4. Sleep in Gilles de la Tourette syndrome.
    Mendelson WB; Caine ED; Goyer P; Ebert M; Gillin JC
    Biol Psychiatry; 1980 Apr; 15(2):339-43. PubMed ID: 6932227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gilles de la Tourette syndrome; extended follow-up.
    Milman DH
    N Y State J Med; 1975 May; 75(6):892-5. PubMed ID: 1055885
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gilles de la Tourette syndrome].
    Lakke JP
    Ned Tijdschr Geneeskd; 1984 Nov; 128(46):2161-4. PubMed ID: 6595541
    [No Abstract]   [Full Text] [Related]  

  • 7. Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol.
    Caine ED; Ludlow CL; Polinsky RJ; Ebert MH
    J Am Acad Child Psychiatry; 1984 Mar; 23(2):147-52. PubMed ID: 6585416
    [No Abstract]   [Full Text] [Related]  

  • 8. Tics and Tourette syndrome.
    Singer HS
    Johns Hopkins Med J; 1982 Jul; 151(1):30-5. PubMed ID: 6953280
    [No Abstract]   [Full Text] [Related]  

  • 9. Visually evoked responses in Tourette syndrome.
    Domino EF; Piggott L; Demetriou S; Culbert J
    Adv Neurol; 1982; 35():115-20. PubMed ID: 6959484
    [No Abstract]   [Full Text] [Related]  

  • 10. Tourette syndrome in the Chinese: a follow-up of 15 cases.
    Mak FL; Chung SY; Lee P; Chen S
    Adv Neurol; 1982; 35():281-3. PubMed ID: 6959500
    [No Abstract]   [Full Text] [Related]  

  • 11. Gilles de la Tourette syndrome in Papua New Guinea.
    Johnson FY
    P N G Med J; 1995 Jun; 38(2):127-32. PubMed ID: 9599974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic treatment in the Tourette syndrome.
    Polinsky RJ; Ebert MH; Caine ED; Ludlow C; Bassich CJ
    N Engl J Med; 1980 Jun; 302(23):1310. PubMed ID: 6929034
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of pharmacological approaches to therapy for Tourette syndrome.
    van Woert MH; Rosenbaum D; Enna SJ
    Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome.
    Singer HS; Tune LE; Butler IJ; Zaczek R; Coyle JT
    Adv Neurol; 1982; 35():177-83. PubMed ID: 6959488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tourette's syndrome.
    Flynn SP; Jacobs I; Guinter W
    J Fam Pract; 1988 Jan; 26(1):27-32. PubMed ID: 3422258
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dopamine agonists and antagonists in Tourette's disease.
    Feinberg M; Carroll BJ
    Arch Gen Psychiatry; 1979 Aug; 36(9):979-85. PubMed ID: 380492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():433-6. PubMed ID: 6959521
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral effects of haloperidol in young Tourette syndrome patients.
    Bogomolny A; Erenberg G; Rothner AD
    Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 20. Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient.
    Meyerhoff JL; Snyder SH
    Psychopharmacologia; 1973; 29(3):211-20. PubMed ID: 4512896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.